Latest Peptide Research
Stay informed about the latest research and developments
Filter Articles
Receptor pharmacology study characterizing melanotan II binding to melanocortin receptors (MC1R, MC3R, MC4R). Analyzes receptor selectivity, signal transduction pathways, and downstream effects in transfected cell expression systems.
Recent research on DSIP: Electronic Prediction of Chemical Contaminants in Aroma of Brewed Roasted Coffee and Quantification of Acrylamide Levels.
Recent research on GH-FRAG 176-191: Chitosan/Hyaluronan and Alginate-Nanohydroxyapatite Biphasic Scaffold as a Promising Matrix for Osteoarthritis Disorders.
Recent research on TB-500: Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro.
Recent research on ARA-290: Erythropoietin-derived peptide ARA290 mediates brain tissue protection through the β-common receptor in mice with cerebral ischemic stroke.
Recent research on GLOW Blend: Computational, optical and feasibility studies of organic luminescence TMB-PPT blend for photovoltaic application.
Cellular biology investigation of epithalon's effects on telomerase activation and potential anti-senescence mechanisms. Examines telomere length maintenance, cell cycle regulation, and longevity-related pathways in cultured cell models.
Recent research on FOXO4-DRI: Cellular Senescence Contributes to the Progression of Hyperoxic Bronchopulmonary Dysplasia.
Recent research on Lys-Glu (Vilon): Graphene oxide nanosheets conjugated PEG-Glu-Lys-Glu copolymer drug delivery system improves drug-loading rates and enables reduction-sensitive drug release and drug tracking.
Comparative study of GHRP-2 and GHRP-6 mechanisms in stimulating growth hormone release through ghrelin receptor pathways. Analyzes potency differences, receptor binding affinities, and downstream signaling cascades in vitro and in vivo models.
Recent research on SLU-PP-332: A Synthetic ERR Agonist Alleviates Metabolic Syndrome.
Recent research on SLU-PP-332: Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function.